0.0650CAD-7.14%Mkt Cap: 12.22M CADP/E: —Last update: 2026-05-26
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabi…
Industry Peers
Drug Manufacturers - Specialty & Generic152.45BSEKP/E 166.3
58.11BTRYP/E 27.8
55.80BEURP/E 22.1
32.54BPLNP/E 21.2
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BEURP/E 30.3
Indicators:|
Key Statistics
Company
Market Cap12.22M CAD
Enterprise Value33.40M CAD
Revenue (TTM)1.75M CAD
Gross Profit730.88K CAD
Net Income (TTM)-9.14M CAD
Revenue/Share0.0090 CAD
Last Price0.0650 CAD
Fiscal Year EndMar 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.60
PEG—
EV/EBITDA-12.79
EV/Revenue19.07
P/S8.59
P/B-0.98
EPS (TTM)-0.05
EPS (Forward)-0.05
52W Range
0.035023% of range0.1650
52W High0.1650 CAD
52W Low0.0350 CAD
Profitability
Gross Margin21.00%
Oper. Margin262.27%
EBITDA Margin-149.03%
Profit Margin-262.70%
ROE121.62%
ROA-49.70%
Growth
Revenue Growth-46.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.97M CAD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt18.36M CAD
Net Debt/EBITDA-7.03
Balance Sheet
Debt/Equity-2.73
Current Ratio0.15
Quick Ratio0.04
Book Value/Sh-0.0820 CAD
Cash/Share0.0020 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 18, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.187.98M
Float160.38M
Insiders14.01%
Institutions0.15%
Short Interest
Short Ratio0.6d
Short % Out.0.02%
Shares Short25.45K
Short (prev mo.)27.37K
Technical
SMA 500.0581 (+11.9%)
SMA 2000.0562 (+15.7%)
Beta0.38
S&P 52W Chg28.31%
Avg Vol (30d)62.29K
Avg Vol (10d)101.29K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—